Follow
Antigen-specific T cells
T cells, a type of CD8 T cells (also called cytotoxic T lymphocyte) that are activated against a specific antigen. CD8 T cells identify and eliminate foreign cells, such as cancer cells or virus-infected cells. Antigen specific T cells are capable of identifying a specific antigen that is specific to the invading cells.
JUN 02, 2021 | 12:00 AM
Ovarian cancer is a deadly disease which is usually diagnosed in advanced stages. Our goal is to develop vaccines to prevent relapse. Natural Th17 T cells protect against recurrence followin...
JUN 02, 2021 | 12:00 AM
Immune checkpoint therapy (ICT) is a front-line treatment for lung cancer; however, low mutational burden and ‘non-T cell inflamed’ signatures predict poor responses to ICT in ~5...
JUN 02, 2021 | 12:00 AM
Rhabdomyosarcoma (RMS) is a soft tissue cancer commonly arising in muscle and is the most common soft tissue cancer in children. Patients with metastatic RMS have a poor prognosis that has n...
MAY 11, 2021 | 8:00 AM
DATE: May 11, 2021 TIME: 8:00am PDT T cells are most important from basic research to therapeutic approaches and play a pivotal role in many diverse application fields such as basic immu...
APR 21, 2021 | 12:00 AM
Engineered cell therapy is an emerging field of science to target and treat cancer. Current strategies include utilizing immune cells such as T cells, NK cells and Macrophages or other cells...
APR 20, 2021 | 5:00 PM
Date: April 20, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers on Oncology - Professor Joan Seoane Prof. Joan Seoane, Group Leader and Director of the Translational Re...
APR 08, 2021 | 5:00 PM
DATE: April 08, 2021 TIME: 08:00am PDT Multi-omics involves the use of different data modalities to study multiple “omes”, such as the genome, transcriptome, epigenome, and/or t...
MAR 16, 2021 | 8:00 AM
DATE: March 09, 2021 TIME: 08:00am PST The COVID-19 pandemic has placed urgency on precise analysis of rare antigen- and virus-specific T cells. At Miltenyi Biotec, we offer a complete workf...
FEB 03, 2021 | 8:00 AM
Date: February 3, 2021 Time: 8:00am (PST), 11:00am (EST) This introduction webinar will provide you with an overview of the general immuno-oncology (IO) research field...
JAN 19, 2021 | 8:00 AM
Date: January 19, 2021 Time: 8:00am (PST), 11:00am (EST) Only a small subset of patients with clear cell Renal Cell Carcinoma (ccRCC) respond to immunotherapy with checkpoint inhibitors. Res...
OCT 08, 2020 | 3:00 PM
The continued rapid expansion of immunotherapies, including both in vivo and ex vivo therapeutics, has driven the development and adoption of novel tools to study, asses and understand these...
SEP 23, 2020 | 12:00 PM
B cells and tertiary lymphoid structures (TLS) promote immunotherapy response 1:00–1:30 pm PDT Presented By: Rafet Basar, MD...
SEP 09, 2020 | 12:00 AM
The regions of our genome responsible for encoding the genes that regulate our immune response are some of the most complex and polymorphic known. This complexity encompasses multiple types...
